Pediatrix Medical Group Reports Third Quarter Results
Business Wire•29/10/2026•06:00 ET
0
Key Highlights
- ➤Q3 net revenue $501.4 million, up 1.7% year over year
- ➤Q3 Adjusted EPS $0.72, up from $0.67 year over year
- ➤Q3 Adjusted EBITDA $85.5 million, down from $87.3 million
- ➤2026 Adjusted EBITDA outlook maintained at $290 million-$300 million
- ➤$83.0 million used for share repurchases during Q3
Expert Statements
Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group
“We are pleased with our results this quarter, driven by both volume and pricing performing ahead of our expectations”
Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group
“We continue to push operating efficiency paired with sector leading care quality, while considering high-value opportunities in adjacent businesses, as they arise.”
Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.59 per share for the three months ended September 30, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.72.
For the 2026 third quarter, Pediatrix reported the following results:
Get started
Create a free account to read the full story.